Lilly USA, LLC
Lilly USA, LLC is the diabetes-focused subsidiary of Eli Lilly and Company, providing FDA-approved insulin therapies and diabetes medications for Type 1, Type 2, and gestational diabetes patients, supported by the LillyDirect digital health platform and Thrive AI Health Coach.
- Company typePublic
- Founded1876
- HeadquartersIndianapolis, United States
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Lilly USA, LLC does
Lilly USA, LLC operates as the diabetes-focused digital and patient-facing subsidiary of Eli Lilly and Company, the Indianapolis-headquartered pharmaceutical corporation listed on NYSE under ticker LLY. The company provides FDA-approved insulin therapies and diabetes medications for Type 1, Type 2, and gestational diabetes patients, distributed through traditional pharmaceutical channels including retail pharmacies, hospital pharmacies, and healthcare provider prescriptions.
The product portfolio spans core pharmaceutical offerings (insulin formulations available as injections or pump delivery), the LillyDirect digital health platform connecting patients with independent virtual and in-person care providers, and the Thrive AI Health Coach for AI-powered personalized lifestyle management. LillyDirect integrates partner services including Healthgrades for in-person provider search and 9amHealth for virtual diabetes care, supporting insurance coverage including Medicare and select Medicaid plans.
The business model combines prescription drug sales (branded and biosimilar insulin products) with direct-to-consumer digital health services. Revenue is generated primarily through pharmaceutical product sales distributed via pharmacy and provider channels, augmented by the LillyDirect platform's role in patient acquisition and care connection. The company serves three primary patient segments—Type 1, Type 2, and gestational diabetes—and operates globally with presence in the United States, India, and the United Kingdom, while leveraging Eli Lilly's century-long diabetes care heritage (founded 1876) as a brand and trust anchor.
Lilly USA, LLC firmographics
Firmographics- Name
- Lilly USA, LLC
- Legal name
- Eli Lilly and Company
- Website
- https://lillydiabetes.com
- Company type
- Public
- Founded year
- 1876
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Lilly USA, LLC is the diabetes-focused subsidiary of Eli Lilly and Company, providing FDA-approved insulin therapies and diabetes medications for Type 1, Type 2, and gestational diabetes patients, supported by the LillyDirect digital health platform and Thrive AI Health Coach.
- Ownership category
- akta.pro rank
Lilly USA, LLC industry classification
Industry- Product category
- Diabetes Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)
- akta.pro secondary industries
- Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Diabetes (General) (HLAKADAA), Type 1 Diabetes Care (HLAKADAB)
Keywords
Where Lilly USA, LLC is headquartered
LocationHeadquarters
- HQ city
- Indianapolis
- HQ country
- United States
- HQ region
- North America
Markets served
Lilly USA, LLC business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Operations, Personnel
Revenue model
- Pharmaceutical product sales: Revenue generated from FDA-approved diabetes medications and insulin products sold through pharmacies and healthcare providers. Includes both branded pharmaceutical products and biosimilar insulin therapies.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Lilly USA, LLC product offering
Product offeringCore offering
Lilly USA, LLC develops, manufactures, and distributes FDA-approved pharmaceutical products for the treatment of diabetes, including insulin therapies and oral medications for Type 1, Type 2, and gestational diabetes. The company also operates the LillyDirect platform, which connects patients with independent virtual and in-person care providers, and offers the Thrive AI Health Coach for AI-powered personalized diabetes lifestyle guidance.
Product overview
Lilly USA, LLC offers a portfolio of FDA-approved diabetes medicines combined with digital health services. The core offerings include Lilly's pharmaceutical treatments for diabetes (Type 1, Type 2, and gestational diabetes), supported by the LillyDirect platform for connecting patients with independent virtual and in-person care providers, and the Thrive AI Health Coach for AI-powered personalized health guidance. The company provides clinical trial participation opportunities as part of its comprehensive diabetes care ecosystem.
Differentiator
Problem solved
Functional benefit
Brands
- LillyDirect: A service providing independent in-person and virtual care options for diabetes and other conditions
- Thrive AI Health Coach
Products and services
- Lilly Diabetes Medicines
Quantifiable outcome
- A1C levels can be managed below 7% with proper treatment and lifestyle modifications
Companies that use Lilly USA, LLC
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Lilly USA, LLC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Lilly USA, LLC partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and supporting.
- Wayne State UniversityminorLilly provides sponsored research funding to Wayne State University's Division of Research & Innovation as part of academic research collaborations in pharmaceutical sciences. This represents one of several pharmaceutical company sponsors (alongside Incyte and Regeneron) supporting university research initiatives.
- HealthgradessupportingHealthgrades serves as an independent search tool integrated into LillyDirect to help patients find in-person diabetes care providers. Patients can filter by insurance, specialty, distance and other criteria through this platform partnership.
- 9amHealthsupporting9amHealth is referenced as an independent virtual care provider option available through LillyDirect's diabetes telehealth platform, offering patients access to diabetes specialists from home.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Lilly USA, LLC competitors and assessment
Company assessmentBroad incumbents
- Novo Nordisk: Global leader in insulin and GLP-1 therapies (Tresiba, Ozempic, NovoLog) with deep diabetes franchise, directly comparable product set to Lilly's diabetes portfolio and similar D2C/patient support ambitions.
- Sanofi: Major diabetes player (Lantus, Toujeo, Apidra) with established patient support programs and ongoing investment in integrated diabetes care, overlapping directly with Lilly's insulin franchise.
- Abbott Diabetes Care: Manufacturer of FreeStyle Libre CGM systems and broader diabetes monitoring portfolio; competes for the same chronic disease patient mindshare targeted by Lilly's bundled care offering.
- Merck & Co. Large-cap pharmaceutical company with a diabetes presence (Steglatro, Januvia) operating branded pharma distribution channels analogous to Lilly's pharmacy/provider distribution model.
- Roche Diabetes Care: Producer of Accu-Chek glucose meters and insulin delivery systems under the broader Roche umbrella; comparable branded diabetes product franchise targeting similar patient segments.
Direct peers
- Insulet Corporation: Maker of the Omnipod tubeless insulin pump, serving the Type 1 diabetes population with a direct-to-patient distributed model analogous to LillyDirect's consumer channel.
- Dexcom: Continuous glucose monitoring (CGM) leader whose devices are central to diabetes management — directly complements and competes for share-of-patient-attention in Lilly's bundled diabetes care stack.
- Medtronic (Diabetes): Insulin pump and integrated CGM business serving the same Type 1 diabetes patients Lilly targets, offering a competing integrated device + service platform to LillyDirect.
Emerging players
- 9amHealth: D2C virtual diabetes care provider listed as a partner inside LillyDirect, offering a comparable independent telehealth-led care model that competes or complements Lilly's bundled offering.
- Virta Health: Virtual clinic for Type 2 diabetes reversal using nutrition-based therapy with digital coaching — direct overlap with Lilly's Thrive AI Health Coach and Type 2 diabetes management focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Lilly USA, LLC social profiles
Digital presenceLilly USA, LLC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lilly USA, LLC leadership team
Management profileNumber of profiles
Lilly USA, LLC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lilly USA, LLC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lilly USA, LLC
What does Lilly USA, LLC do?
Lilly USA, LLC develops, manufactures, and distributes FDA-approved pharmaceutical products for the treatment of diabetes, including insulin therapies and oral medications for Type 1, Type 2, and gestational diabetes. The company also operates the LillyDirect platform, which connects patients with independent virtual and in-person care providers, and offers the Thrive AI Health Coach for AI-powered personalized diabetes lifestyle guidance.
Is Lilly USA, LLC a public or private company?
Lilly USA, LLC is a public company. It is classified as corporate owned and is currently operating.
When was Lilly USA, LLC founded?
Lilly USA, LLC was founded in 1876. It employs 1 to 10 people.
Where is Lilly USA, LLC based?
Lilly USA, LLC is headquartered in Indianapolis, United States, in the North America region.
How does Lilly USA, LLC make money?
One revenue line is on record: pharmaceutical product sales.
Who are Lilly USA, LLC's main competitors?
Broad incumbents on record are Novo Nordisk, Sanofi, Abbott Diabetes Care, Merck & Co. and Roche Diabetes Care. Direct peers are Insulet Corporation, Dexcom and Medtronic (Diabetes). Emerging players are 9amHealth and Virta Health.
Does Lilly USA, LLC have an API?
No public API is recorded for Lilly USA, LLC.
What industry is Lilly USA, LLC in?
Lilly USA, LLC's product category is Diabetes Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity), with a secondary code of HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators). Its NAICS code is 325412 and its SIC code is 2834.